ID: ALA5207294

Max Phase: Preclinical

Molecular Formula: C17H13NO4

Molecular Weight: 295.29

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1ccc2c(c1)C(=O)C(=O)N2CCc1ccccc1

Standard InChI:  InChI=1S/C17H13NO4/c19-15-13-10-12(17(21)22)6-7-14(13)18(16(15)20)9-8-11-4-2-1-3-5-11/h1-7,10H,8-9H2,(H,21,22)

Standard InChI Key:  YTZILBMLXFAYAL-UHFFFAOYSA-N

Associated Targets(Human)

PARK7 Tbio Parkinson disease protein 7 (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 295.29Molecular Weight (Monoisotopic): 295.0845AlogP: 2.16#Rotatable Bonds: 4
Polar Surface Area: 74.68Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.96CX Basic pKa: CX LogP: 2.49CX LogD: -0.70
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.88Np Likeness Score: -0.57

References

1. Maksimovic I, Finkin-Groner E, Fukase Y, Zheng Q, Sun S, Michino M, Huggins DJ, Myers RW, David Y..  (2021)  Deglycase-activity oriented screening to identify DJ-1 inhibitors.,  12  (7.0): [PMID:34355187] [10.1039/D1MD00062D]

Source